Firy Inc. vs TransMedics Group Inc — how do they compare? Firy Inc. trades at $12.03 (market cap $199.80M), while TransMedics Group Inc trades at $78.15 (market cap $2.74B). The key difference: TransMedics Group Inc is far larger — about 13.7× Firy Inc.'s market cap, and Firy Inc. is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Firy Inc. for 13 Days and TransMedics Group Inc for 24 Days on average.
| FIRY | TMDX | |
|---|---|---|
Market Cap | $199.80M | $2.74B |
Volume | 92,993 | 949,331 |
Sector | Technology | Health |
52-Week High | $13.10 | $150.42 |
52-Week Low | $2.28 | $61.99 |
Typical Hold Time | 13 Days | 24 Days |
Enterprise Value | $168.40M | $3.13B |
Signals from Pluang's Aura AI — not financial advice
FIRY trades at $12.18, up 2.78% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $31.0 million but missed EPS expectations with a net loss. Despite a high gross margin of 87.76%, profitability remains challenged with negative net income margin and ROE. Recent developments include a $719 million legal victory and board appointment of Marc Lasry.
The outlook remains cautious due to persistent cash burn and negative earnings, though the legal win provides potential upside. Investment opportunity hinges on successful monetization of legal claims and operational turnaround. Key risks include ongoing cash flow deficits, competitive pressures, and uncertainty around debt collection from Papaya Gaming.
TransMedics Group (TMDX) trades at $78.17, down 3.58% on the day, with a bearish technical signal and mixed earnings history. The company reported strong 2025 results with $605.49M revenue and $190.29M net income, but 2026 projections show margin compression. Recent news highlights insider buying and leadership changes alongside legal investigations into fiduciary duties, creating a complex sentiment backdrop.
The stock offers growth potential with a consensus price target of $99.75, but faces risks from earnings misses, margin pressure, and ongoing legal scrutiny. Analyst consensus remains bullish with 69% buy ratings, yet investors must weigh robust profitability metrics against execution and regulatory uncertainties.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →